BLOOM43 Wearable Device Debuts in U.S. to Reduce Breast Surgery Complications
Plexāā has launched its BLOOM43 platform in the U.S., a wearable and app designed to improve surgical outcomes for breast surgery patients through preconditioning.
Plexāā has launched its BLOOM43 platform in the U.S., a wearable and app designed to improve surgical outcomes for breast surgery patients through preconditioning.
The regenerative biostimulator is now certified for use in four new body areas.